Osh project, fighting TB
Tuberculosis (TB) is one of the world’s biggest global health crises. Killing 1.4 million people in 2019, TB is the world’s deadliest infectious disease (WHO).

Obsolete treatments, the lack of an effective vaccine, and the lack of suitable diagnostic tools make it difficult to control the global TB epidemic. Some gains have been made in recent years; the first new TB drugs in half a century and the trial of a shorter course of treatment for drug-resistant TB. But the harsh reality remains - 10 million people fell sick with TB in 2019 and nearly half a million developed drug-resistant TB, which is much harder to treat. The majority go undiagnosed and therefore untreated.


Quick facts about tuberculosis

MDR-TB Project Yerevan

Drug-resistant tuberculosis: 30 years of MSF in Armenia

Project Update 21 Dec 2018
MSF HIV Testing Clinic's in Conakry
Access to medicines

HIV and TB treatment at risk as countries gradually lose Global Fund support

Press Release 13 Nov 2018
TB programs in Gulf Province and Port Moresby

High prices restrict access to best drug-resistant tuberculosis treatment

Press Release 23 Oct 2018
Sibongile Xesha - MSF Treatment For TB in South Africa

DR-TB Drugs Under the Microscope, 5th Edition (Abridged)

msfaccess.org 22 Oct 2018
MSF TB Treatment in Mumbai, India

Global leaders must make bold commitments at first-ever UN tuberculosis summit

Press Release 25 Sep 2018
TB treatments yield promising results in the Chechen Republic

Open Letter to J&J: Calling for affordable access to critical TB drug bedaquiline

msfaccess.org 17 Sep 2018
Insein clinic, for treatment for HIV, TB, and Hepatitis C in Yangon. By Alessandro Penso, Feb 2018.

Improved treatment options recommended by the World Health Organization

Press Release 17 Aug 2018
Insein clinic, for treatment for HIV, TB, and Hepatitis C in Yangon. By Alessandro Penso, Feb 2018.

Last-minute pressure to drop language on protecting access to affordable medicines from TB Summit declaration negotiations

Press Release 20 Jul 2018

EndTB: Bedaquiline- and delamanid- containing regimens achieve excellent interim treatment response without safety concerns

endtb.org 13 Jul 2018

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. Read all our Tuberculosis-related articles on our dedicated Field Research website.

View site
Osh project, fighting TB